The Claim

Autoantibodies against selenoprotein P are detected in 9.6% to 15.6% of individuals diagnosed with chronic fatigue syndrome and in 0.9% to 2.0% of healthy individuals, indicating a statistically significant difference in prevalence between the two groups.

Source: Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
54score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

A specific type of antibody that targets selenoprotein P is found in a higher percentage of people with chronic fatigue syndrome than in people without the condition.

See the scientific wording

Autoantibodies against selenoprotein P are present in 9.6% to 15.6% of individuals with chronic fatigue syndrome, compared to 0.9% to 2.0% in healthy controls, suggesting a strong association between these autoantibodies and the condition, potentially indicating a distinct biological subgroup.

What the research says

1 study

  1. Study: Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone

    Scientists found that a small group of people with chronic fatigue syndrome have unusual antibodies that interfere with how selenium moves in the body, and these antibodies are much rarer in healthy people. This suggests that for some people with chronic fatigue, their symptoms might be linked to this specific biological problem.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.